These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15234632)

  • 21. [Quality assurance of results of clinical chemical analyses in Danish hospital laboratories].
    Raabo E; Bartels PD; Blom M; Christensen NJ; Hansen MS; Jørgensen PJ; Olsen JS; Petersen AW; Uldall A
    Ugeskr Laeger; 1992 Jun; 154(23):1627-31. PubMed ID: 1631996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art.
    Haeckel R; Wosniok W
    Clin Chem Lab Med; 2011 Apr; 49(4):623-35. PubMed ID: 21345158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 3 automated assays for C-reactive protein in end-stage renal disease: clinical and epidemiological implications.
    Maggiore U; Cristol JP; Canaud B; Dupuy AM; Formica M; Pozzato M; Panichi V; Consani C; Metelli MR; Sereni L; De Nitti C; David S; Tetta C
    J Lab Clin Med; 2005 Jun; 145(6):305-8. PubMed ID: 15976758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicentre evaluation of the Ektachem DT60-, Reflotron- and Seralyzer III systems.
    Römer M; Haeckel R; Henco A; Vogt M; Thomas L; Keller HE; Appel W
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):547-83. PubMed ID: 1457619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
    Meijer P; Haverkate F; Kluft C
    Thromb Haemost; 2006 Nov; 96(5):584-9. PubMed ID: 17080214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of laboratory data].
    Keller H
    Schweiz Med Wochenschr; 1991 Dec; 121(50):1861-9. PubMed ID: 1759145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graphical interpretation of analytical data from comparison of a field method with reference method by use of difference plots.
    Petersen PH; Stöckl D; Blaabjerg O; Pedersen B; Birkemose E; Thienpont L; Lassen JF; Kjeldsen J
    Clin Chem; 1997 Nov; 43(11):2039-46. PubMed ID: 9365386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence based evaluation of immuno-coagulatory interventions in critical care.
    Afshari A
    Dan Med Bull; 2011 Sep; 58(9):B4316. PubMed ID: 21893014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of two compact analyzers used for lipid analysis.
    McKenney JM; Fary DF; Miller G; Proctor JD; Chinchili VM
    J Fam Pract; 1993 May; 36(5):526-33. PubMed ID: 8482937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of analytical error on the assessment of cardiac risk by the high-sensitivity C-reactive protein and lipid screening model.
    Middleton J
    Clin Chem; 2002 Nov; 48(11):1955-62. PubMed ID: 12406981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of regional guidelines for intrapartum electronic fetal monitoring in women at low obstetric risk.
    Hinsliff SW; Hindley C; Thomson AM
    Midwifery; 2004 Dec; 20(4):345-57. PubMed ID: 15571883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consensus guidelines for anticardiolipin antibody testing.
    Wong RC;
    Thromb Res; 2004; 114(5-6):559-71. PubMed ID: 15507292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeatability imprecision from analysis of duplicates of patient samples and control materials.
    Kallner A; Theodorsson E
    Scand J Clin Lab Invest; 2020 May; 80(3):210-214. PubMed ID: 31899972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeating tests: different roles in research studies and clinical medicine.
    Monach PA
    Biomark Med; 2012 Oct; 6(5):691-703. PubMed ID: 23075249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals.
    Røraas T; Petersen PH; Sandberg S
    Clin Chem; 2012 Sep; 58(9):1306-13. PubMed ID: 22761475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The number of replicates, and pooling versus individual measurements for analytical imprecision calculations: Does it matter?
    Tecles F; Muñoz A; Cerón JJ; Freeman K
    Vet Clin Pathol; 2020 Mar; 49(1):112-118. PubMed ID: 32162347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical goal-setting for monitoring patients when two analytical methods are used.
    Petersen PH; Fraser CG; Westgard JO; Larsen ML
    Clin Chem; 1992 Nov; 38(11):2256-60. PubMed ID: 1424120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical goals for interference.
    Fuentes-Arderiu X; Fraser CG
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():393-5. PubMed ID: 1892351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing the power of quality-control rules to detect persistent increases in random error.
    Parvin CA
    Clin Chem; 1992 Mar; 38(3):364-9. PubMed ID: 1547553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.